Latest News

HOPA logo
Advocacy

HOPA Signs Letters Defending Medicaid, NIH, and More Against Funding Cuts

HOPA has joined forces with multiple national health organizations to speak out against proposed cuts to Medicaid, the NIH, and the future of optimized cancer care.

ASCO 2025 attendees
Membership

ASCO 2025 Recap: HOPA's Impact in Chicago

On May 30-June 1, a group of eight HOPA staff and volunteers once again traveled to Chicago, Illinois, for the ASCO Annual Meeting - the largest oncology conference in the world, with about 50,000 attendees.

oncology pharmacist at work with patients
Advocacy

Time to Complete Oncology Pharmacist Tasks: A Joint Opinion of HOPA and American College of Clinical Pharmacy's Hematology/Oncology Practice and Research Network

HOPA and the Hematology/Oncology Practice and Research Network (PRN) of the ACCP published research producing the first comprehensive consensus statements on the average time for a U.S.-based oncology pharmacist to complete common care-related tasks.

HOPA logo
Advocacy

Together We Can Save Cancer Research - and Lives

In the past two decades, extraordinary progress has been made in the fight against cancer. However, with Congress determined to reduce federal spending, entire cancer research, prevention, and surveillance programs are on the verge of elimination.

Reem Ghandour at AC2025
Membership HOPA News

Powering Through Uncertainty and Doubt: My Journey as a Non-Traditional PGY2 Oncology Resident

In this essay from the most recent issue of HOPA News, Reem M. Ghandour, PharmD, BCPS, shares insights into their non-traditional path and the lessons learned along the way.

HOPA Annual Conference 2025 sign image
Membership

HOPA Annual Conference 2025 Reaches New Heights in Portland, Sets Attendance Record

HOPA 2025 drew 1,702 registrants to Portland, Oregon this spring, surpassing its precious record.

Pharmacist with technology
HOPA News Late Breaking News

Late-Breaking HOPA News: AI Integration in Pharmacy

Aracely Sosa, PharmD; Katelyn Toeniskoetter, PharmD, BCOP; and Pearl Abraham, PharmD, BCPS, BCOP, dive into the basics and beyond of AI integration in pharmacy.

Mesenchymal stromal cells
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Remestemcel-L-rknd

Erin Lexner, PharmD, BCPS, PGY-2 Oncology Pharmacy Resident, and Christine Barrett, PharmD, BCOP, Oncology Pharmacy Specialist - both from Mary Babb Randolph Cancer Center at West Virginia University Hospitals - write about remestemcel-L-rknd.

Diffuse large B-cell lymphoma
HOPA News Late Breaking News

Late-Breaking HOPA News: The Emerging Use of Bispecific Antibodies with Chemotherapy in Diffuse Large B-Cell Lymphoma

Katelynn Granger, PharmD, BCOP, and Matthew Warrick, PharmD, BCPS, BCOP, dive into the emerging use of bispecific antibodies with chemotherapy in diffuse large B-cell lymphoma.

Robert Mancini at HOPA AC 2025
HOPA Members

HOPA President Combines People-First Approach with Oncology Pharmacy Expertise

HOPA officially welcomed Dr. Robert Mancini as its President at its annual conference in Portland, Oregon on April 11, 2025.

Neurofibromatosis
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Mirdametinib

Ramsey Shane, PharmD, MPH, PGY1 Pharmacy Resident, and Rebecca Pokorny, PharmD, BCPS, BCOP, Clinical Pharmacist Specialist Neuro-Oncology - both from Vanderbilt University Medical Center, Nashville, TN - write about mirdametinib (Gomekli).

Lung cancer x-ray image
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Ensartinib

Savannah Young, PharmD, PGY1 Pharmacy Resident, from Sarasota Memorial Hospital, Sarasota, FL, and Kiera Roubal, PharmD, BCOP, Clinical Oncology Pharmacist Specialist, from Medical University of South Carolina, Charleston, SC, write about ensartinib.